Last week, European deep tech was zoned in on biotech and medtech, with over €100M deployed across biotech solutions while public funding boosted commercialization pathways.
Nobel recognition highlighted EU research excellence, as Michel H. Devoret took it home for “the discovery of macroscopic quantum mechanical tunnelling and energy quantisation in an electric circuit”.
Policy & ecosystem
- EU-funded physicist wins 2025 Nobel Prize [EC]
- Commission launches two strategies to speed up AI uptake in European industry and science [Press release]
- Europe’s venture-capital market shows renewed optimism [EIF]
- RTU researchers receive EUR 1.8 million to advance innovations toward the market [Labs of Latvia]
Biotech & medtech
- NanoPhoria Bioscience (Milan) secures €83.5M Series A for heart failure therapy and nano-in-micro delivery platform [Startup Rise]
- Nanoligent (Barcelona) raises €12M to fight cancer with precision nanodrugs [Silicon Canals]
- Phagos gets €25M boost to combat bacterial diseases [Tech.eu]
- Lauxera Capital closes €400M health tech fund, bets big on European innovation going global [TFN]
Quantum & frontier tech
- FirstQFM (Stockholm) secures €1.2M pre-seed funding [Startup Rise]
